E-cigarettes: Effects in phagocytosis and cytokines response against Mycobacterium tuberculosis

PLoS One. 2020 Feb 10;15(2):e0228919. doi: 10.1371/journal.pone.0228919. eCollection 2020.

Abstract

Cigarette smoking and tuberculosis are a significant cause of death worldwide. Several epidemiological studies have demonstrated cigarette smoking is a risk factor for tuberculosis. Electronic cigarettes have recently appeared as a healthier alternative to conventional smoking, although their impact in tuberculosis is not well understood. The aim of this study was to explore the effect of electronic cigarettes in phagocytosis of Mycobacterium tuberculosis and cytokines production. In vitro infection was carried out by exposing THP-1 macrophages to four electronic vapor extracts and the intracellular burden of M. tuberculosis was determined. The percentage of infection was evaluated by confocal microscopy and the cytokine production by Luminex. A reduction of intracellular M. tuberculosis burden in THP-1 macrophages was found after its exposure to electronic vapor extract; the same trend was observed by confocal microscopy when Mycobacterium bovis BCG-GFP strain was used. Electronic cigarettes stimulate a pro-inflammatory cytokine response. We conclude that electronic cigarettes impair the phagocytic function and the cytokine response to M. tuberculosis.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Cell Survival
  • Cytokines / biosynthesis*
  • Electronic Nicotine Delivery Systems*
  • Humans
  • Immunity, Innate
  • Inflammation Mediators / metabolism
  • Macrophages / immunology
  • Macrophages / microbiology
  • Macrophages / pathology
  • Mycobacterium tuberculosis / growth & development
  • Mycobacterium tuberculosis / immunology
  • Mycobacterium tuberculosis / pathogenicity*
  • Phagocytosis*
  • Smoke / adverse effects
  • Smoking / adverse effects*
  • THP-1 Cells

Substances

  • Cytokines
  • Inflammation Mediators
  • Smoke

Grants and funding

This work was supported by: SEPAR (Spanish Society for Pulmonology and Thoracic Surgery; Extraordinary Call for Research PII Smoking, Research Project nº:16/024); European Respiratory Society Long-Term Research Fellowship (LTRF-2015-5934); Instituto de Salud Carlos III (PI16/1912 y PI17/01139 projects, integrated in the National Plan R+D+I and funded by the ISCIII and the European Regional Development Fund.) and the CERCA Programme/Generalitat de Catalunya. José Domínguez is an investigator of the Program Miguel Servet from Instituto de Salud Carlos III and Pablo Rodríguez-Fernández is the recipient of a fellowship from the Spanish Ministry of Science, Innovation and Universities, as a part of the Program Training of University Staff (FPU14/01854). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.